Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chitinase 1 (Ov-CHT1) is a critical enzyme secreted by the parasitic nematode Onchocerca volvulus, which is responsible for causing onchocerciasis, or river blindness, in humans (UniProt P29030). As a member of the glycosyl hydrolase family 18, this enzyme is primarily involved in the degradation of chitin, a structural polysaccharide essential for the parasite's life cycle (Wu et al., 1996). Specifically, Ov-CHT1 facilitates the molting process (ecdysis) where third-stage larvae (L3) transition into fourth-stage larvae (L4), and it is also implicated in the development and release of microfilariae from the adult female worm (Adam et al., 1996). Because humans do not synthesize chitin, this enzyme represents a highly selective therapeutic target for the development of new anthelmintic drugs (Gooday, 1996). Inhibitors such as allosamidin have demonstrated the ability to arrest larval development by blocking chitinase activity, suggesting that targeting this enzyme could provide a macrofilaricidal effect or interrupt transmission (Adam et al., 1996). Current drug discovery efforts focus on identifying potent, small-molecule inhibitors that maintain high selectivity over human chitinases like chitotriosidase to minimize potential off-target effects.
Inhibition of chitinase activity prevents the degradation of chitinous structures, thereby arresting larval molting and microfilarial development (Adam et al., 1996).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chitinase 1 (Onchocerca volvulus) (Ov-CHT1).